Brief: Ascendis Pharma A/S Reports Q1 Loss Per Share Of EUR 1.24
May 30 (Reuters) - Ascendis Pharma A/S ASND.O :
* REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS
* Q1 LOSS PER SHARE EUR 1.24
* Q1 REVENUE EUR 5.4 MILLION
* Q1 REVENUE ESTIMATE EUR 370,000 -- REFINITIV IBES DATA
* Q1 EARNINGS PER SHARE ESTIMATE EUR -1.00 -- REFINITIV IBES
DATA
* AS OF MARCH 31, 2019, COMPANY HAD CASH AND CASH
EQUIVALENTS OF
EUR 696.7 MILLION COMPARED TO EUR 277.9 MILLION AS OF DECEMBER
31, 2018
Source text for Eikon: ID:nGNX6SfxZP
Further company coverage: ASND.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ascendis Pharma A/S
See all newsAscendis Pharma tumbles on Novo Nordisk collab termination
BioMarin climbs on global patent settlement with Ascendis
Brief: Ascendis Announces Oral Presentation Of Week 104 Data From Its Pivotal Trial Of Transcon® CNP (Navepegritide) At Isds 2026
Brief: Eyconis Announces Initiation Of First-In-Human Clinical Trial Of Eyc-0305 In Treatment-Naïve Wet Age-Related Macular Degeneration Patients
Ascendis Pharma A/S reports results for the quarter ended June 30 - Earnings Summary